Hepatitis Virus Testing Market: By Disease Type, By Techniques, By Modality, By End User, and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Hepatitis Virus Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Disease Type (Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis A, and Hepatitis E), By Techniques (Immunoassays, Molecular Assays, and Others), By Modality (Laboratory Based Test and Point-Of-Care Assays), By End User (Hospitals and Clinics, Diagnostic Centers, Blood Banks, and Others), and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Hepatitis Virus Testing Market size was valued at US$ 4,163.8 million in 2023 and is poised to grow at a CAGR of 5.9% from 2024-2030. The hepatitis virus testing market is a rapidly growing segment of the global diagnostics industry focused on the detection and diagnosis of hepatitis virus infections. Hepatitis is a category of viral diseases that predominantly affect the liver and can cause a wide range of liver damage, from moderate inflammation to severe cirrhosis and even liver failure. Hepatitis viruses are categorized as Hepatitis A, B, C, D, and E. Each type of hepatitis virus has different transmission routes and clinical characteristics, making accurate and timely testing crucial for appropriate patient management and treatment. Hepatitis infections remain a major public health problem across the world, with millions of new cases recorded each year. According to WHO, an estimated 58 million people worldwide have chronic hepatitis C virus infection, with around 1.5 million new infections happening each year.

This high frequency of hepatitis infections is a key factor driving the demand for testing and screening services to detect affected people, ultimately driving the hepatitis virus testing market. Moreover, growing awareness and screening programs coupled with increasing healthcare expenditure contribute to the growth of the hepatitis virus testing market. On top of that, growing demand in emerging markets is creating significant opportunities for the growth of the hepatitis virus testing market. However, the high cost of hepatitis virus testing, especially for advanced molecular diagnostic techniques, can be a significant barrier to access hepatitis virus testing. The Companies operating in the hepatitis virus testing market are expanding their product portfolios by offering comprehensive testing solutions.

Hepatitis Virus Testing Market Key Developments:
  • In July 2022, Roche introduced new hepatitis C virus diagnostic test the Elecsys HCV Duo immunoassay.
  • In November 2021, Molecular Testing Labs launched innovative hepatitis C test options to determine both positivity and viral load.

summary download arrow Download Free Sample

Global Hepatitis Virus Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Hepatitis Virus Testing Market Dynamics

The continuous development of advanced diagnostic technologies, such as molecular testing, nucleic acid amplification techniques, and immunoassays, enhances the accuracy, speed, and accessibility of hepatitis virus testing. These innovations drive the hepatitis virus testing market growth as healthcare providers seek efficient and reliable testing methods. Moreover, point-of-care testing (POCT) for the hepatitis virus has gained popularity due to its ability to provide rapid results at the patient's bedside or in community settings. POCT allows for timely diagnosis and immediate initiation of treatment, especially in remote or resource-limited areas, which further contribute to the growth and development of the hepatitis virus testing market.

Global Hepatitis Virus Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 4,163.8 million

Market CAGR

5.9%

By Disease Type

  • Hepatitis B
  • Hepatitis C
  • Hepatitis D
  • Hepatitis A
  • Hepatitis E

By Techniques

  • Immunoassays
  • Molecular Assays
  • Others

By Modality

  • Laboratory Based Test
  • Point-Of-Care Assays

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Blood Banks
  • Others

Key Features of the Report

  • The hepatitis virus testing market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The hepatitis virus testing market size was valued at US$ 4,163.8 million in 2023 and is poised to grow at a CAGR of 5.9 % over 2024-2030.

The growing demand of emerging markets and point-of-care testing advancements, are some of the factors that create potential opportunities for the growth of the hepatitis virus testing market.

Increasing adoption of molecular testing and shift towards automated testing systems are some of the major trends in the hepatitis virus testing market.

Innovita Biological Technology Co. Ltd., General Biologicals Corporation, Nantong, Diagnos Biotechnology Co. Ltd., Transasia Bio-Medicals Ltd., BioGenex , F. Hoffmann- La Roche AG, Diasorin S.p.A, bioMeriuex SA, MedMira Inc, Beckman Coulter Inc, Qiagen GmbH, Bio-Rad Laboratories Inc., Abnova Corporation, Abbott Laboratories, Hologic Inc.are a few companies operating in hepatitis virus testing market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Hepatitis Virus Testing Market Introduction 
2.1. Global Hepatitis Virus Testing Market  - Taxonomy
2.2. Global Hepatitis Virus Testing Market  - Definitions
2.2.1. Disease Type
2.2.2. Techniques
2.2.3. Modality
2.2.4. End Users
2.2.5. By Region
3. Global Hepatitis Virus Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
3.8. USP
3.9. Macro Trends
3.10. Epidemiology
4. Global Hepatitis Virus Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Hepatitis Virus Testing Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Hepatitis B
5.1.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Hepatitis C
5.2.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Hepatitis D
5.3.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Hepatitis A
5.4.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Hepatitis E
5.5.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Hepatitis Virus Testing Market  By Techniques, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Immunoassays
6.1.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Molecular Assays
6.2.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Hepatitis Virus Testing Market By Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Laboratory-Based Test
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Point-Of-Care Assays
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8. Global Hepatitis Virus Testing Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals and Clinics
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) 
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.1.3. Market Opportunity Analysis  
8.2. Diagnostic Centers 
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) 
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.2.3. Market Opportunity Analysis  
8.3. Blood Banks 
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) 
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.3.3. Market Opportunity Analysis  
8.4. Others 
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) 
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)  
8.4.3. Market Opportunity Analysis  
8.Global Hepatitis Virus Testing Market  By By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Latin America
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Middle East and Africa (MEA)
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
8.6.  Global Hepatitis Virus Testing Market - Opportunity Analysis Index, By Techniques, Disease Type, Modality, End Users,  ,  ,  , and By Region, 2024 - 2030
9. North America Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Disease Type Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1. Hepatitis B
9.1.2. Hepatitis C
9.1.3. Hepatitis D
9.1.4. Hepatitis A
9.1.5. Hepatitis E
9.2. Techniques Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1. Immunoassays
9.2.2. Molecular Assays
9.2.3. Others
9.3. Modality Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1. Laboratory-Based Test
9.3.2. Point-Of-Care Assays
9.4. End Users Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1. Hospitals and Clinics
9.4.2. Diagnostic Centers
9.4.3. Blood Banks
9.4.4. Others
9.5. Country Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.5.1. United States of America (USA)
9.5.2. Canada
10. Europe Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Disease Type Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1. Hepatitis B
10.1.2. Hepatitis C
10.1.3. Hepatitis D
10.1.4. Hepatitis A
10.1.5. Hepatitis E
10.2. Techniques Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1. Immunoassays
10.2.2. Molecular Assays
10.2.3. Others
10.3. Modality Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1. Laboratory-Based Test
10.3.2. Point-Of-Care Assays
10.4. End Users Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1. Hospitals and Clinics
10.4.2. Diagnostic Centers
10.4.3. Blood Banks
10.4.4. Others
10.5. Country Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1. Germany
10.5.2. France
10.5.3. Italy
10.5.4. United Kingdom (UK)
10.5.5. Spain
10.5.6. Rest of EU
11. Asia Pacific (APAC) Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Disease Type Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1. Hepatitis B
11.1.2. Hepatitis C
11.1.3. Hepatitis D
11.1.4. Hepatitis A
11.1.5. Hepatitis E
11.2. Techniques Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1. Immunoassays
11.2.2. Molecular Assays
11.2.3. Others
11.3. Modality Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1. Laboratory-Based Test
11.3.2. Point-Of-Care Assays
11.4. End Users Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1. Hospitals and Clinics
11.4.2. Diagnostic Centers
11.4.3. Blood Banks
11.4.4. Others
11.5. Country Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1. China
11.5.2. India
11.5.3. Australia and New Zealand (ANZ)
11.5.4. Japan
11.5.5. Rest of APAC
12. Latin America Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Disease Type Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1. Hepatitis B
12.1.2. Hepatitis C
12.1.3. Hepatitis D
12.1.4. Hepatitis A
12.1.5. Hepatitis E
12.2. Techniques Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1. Immunoassays
12.2.2. Molecular Assays
12.2.3. Others
12.3. Modality Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1. Laboratory-Based Test
12.3.2. Point-Of-Care Assays
12.4. End Users Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1. Hospitals and Clinics
12.4.2. Diagnostic Centers
12.4.3. Blood Banks
12.4.4. Others
12.5. Country Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of LA
13. Middle East and Africa (MEA) Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Disease Type Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1. Hepatitis B
13.1.2. Hepatitis C
13.1.3. Hepatitis D
13.1.4. Hepatitis A
13.1.5. Hepatitis E
13.2. Techniques Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1. Immunoassays
13.2.2. Molecular Assays
13.2.3. Others
13.3. Modality Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1. Laboratory-Based Test
13.3.2. Point-Of-Care Assays
13.4. End Users Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1. Hospitals and Clinics
13.4.2. Diagnostic Centers
13.4.3. Blood Banks
13.4.4. Others
13.5. Country Analysis,  2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
14.  Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Innovita Biological Technology Co. Ltd. 
14.2.2. General Biologicals Corporation 
14.2.3. Nantong Diagnos Biotechnology Co. Ltd. 
14.2.4. Transasia Bio-Medicals Ltd.
14.2.5. BioGenex  
14.2.6. F. Hoffmann- La Roche AG
14.2.7. Diasorin S.p.A
14.2.8. bioMeriuex SA
14.2.9. MedMira Inc
14.2.10. Beckman Coulter Inc 
14.2.11. Qiagen GmbH
14.2.12. Bio-Rad Laboratories Inc.
14.2.13. Abnova Corporation
14.2.14. Abbott Laboratories
14.2.15. Hologic Inc.
15.  Research Methodology
16.  Key Assumptions and Acronyms

Key Market Players

  • Innovita Biological Technology Co. Ltd.
  • General Biologicals Corporation
  • Nantong Diagnos Biotechnology Co. Ltd.
  • Transasia Bio-Medicals Ltd.
  • BioGenex
  • Hoffmann- La Roche AG
  • Diasorin S.p.A
  • bioMeriuex SA
  • MedMira Inc
  • Beckman Coulter Inc
  • Qiagen GmbH
  • Bio-Rad Laboratories Inc.
  • Abnova Corporation
  • Abbott Laboratories
  • Hologic Inc.

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market